Atrial fibrillation and sinus tachycardiac may worsen hemodynamic change and heart function.
房颤和窦加重
力学改变和使心功能恶化。
Atrial fibrillation and sinus tachycardiac may worsen hemodynamic change and heart function.
房颤和窦加重
力学改变和使心功能恶化。
Objective To evaluate the efficacy and safety of intravenous diltiazem and cediland (lanatoside C) for treatment of rapid ventricular rate in atrial fibrillation and flutter.
目的观察和比较静脉注射地尔硫、毛花甙C控制快心房颤
(房颤)和心房扑
(房扑)心室率的即时疗效及安全性。
Objective To evaluate the efficacy and safety of intravenous fenopraine and lanatoside C for the treatment of rapid ventricular rate in patients with atrial fibrillation and congestive heart failure.
目的比较静脉罗帕酮与毛花苷丙治疗快
心房颤
(简称房颤)并发充
性心力衰竭(心衰)患者心室率的即时效
及安全性。
声明:以上例句、词性分类均由互联网资源自生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Atrial fibrillation and sinus tachycardiac may worsen hemodynamic change and heart function.
房窦
加重血流动力学改变
使
功能恶化。
Objective To evaluate the efficacy and safety of intravenous diltiazem and cediland (lanatoside C) for treatment of rapid ventricular rate in atrial fibrillation and flutter.
目的观察比较静脉注射地
、
花甙C控制快
房
动(房
)
房扑动(房扑)
室率的即时疗效及安全性。
Objective To evaluate the efficacy and safety of intravenous fenopraine and lanatoside C for the treatment of rapid ventricular rate in patients with atrial fibrillation and congestive heart failure.
目的比较静脉应用普罗帕酮与花苷丙治疗快
房
动(简称房
)并发充血性
力衰竭(
衰)患者
室率的即时效应及安全性。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Atrial fibrillation and sinus tachycardiac may worsen hemodynamic change and heart function.
房颤和窦血流动力学改变和使心功能恶化。
Objective To evaluate the efficacy and safety of intravenous diltiazem and cediland (lanatoside C) for treatment of rapid ventricular rate in atrial fibrillation and flutter.
目的观察和比较静脉注射地尔硫、毛花甙C控制快心房颤动(房颤)和心房扑动(房扑)心室率的即时疗效及安全性。
Objective To evaluate the efficacy and safety of intravenous fenopraine and lanatoside C for the treatment of rapid ventricular rate in patients with atrial fibrillation and congestive heart failure.
目的比较静脉应用普与毛花苷丙治疗快
心房颤动(简称房颤)并发充血性心力衰竭(心衰)患者心室率的即时效应及安全性。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Atrial fibrillation and sinus tachycardiac may worsen hemodynamic change and heart function.
房颤窦
加重血流动力学改变
使心功能恶化。
Objective To evaluate the efficacy and safety of intravenous diltiazem and cediland (lanatoside C) for treatment of rapid ventricular rate in atrial fibrillation and flutter.
目比较静脉注射地尔硫、毛花甙C控制快
心房颤动(房颤)
心房扑动(房扑)心室
时疗效及安全性。
Objective To evaluate the efficacy and safety of intravenous fenopraine and lanatoside C for the treatment of rapid ventricular rate in patients with atrial fibrillation and congestive heart failure.
目比较静脉应用普罗帕酮与毛花苷丙治疗快
心房颤动(简称房颤)并发充血性心力衰竭(心衰)患者心室
时效应及安全性。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件点;若发现问题,欢迎向我们指正。
Atrial fibrillation and sinus tachycardiac may worsen hemodynamic change and heart function.
房颤和窦加重血流动
学改变和使心功能恶化。
Objective To evaluate the efficacy and safety of intravenous diltiazem and cediland (lanatoside C) for treatment of rapid ventricular rate in atrial fibrillation and flutter.
目的观察和比较静脉注射地尔硫、毛花甙C控制快心房颤动(房颤)和心房扑动(房扑)心室率的即时疗效及安全性。
Objective To evaluate the efficacy and safety of intravenous fenopraine and lanatoside C for the treatment of rapid ventricular rate in patients with atrial fibrillation and congestive heart failure.
目的比较静脉应用普罗帕酮与毛花苷丙治疗快心房颤动(简称房颤)并发充血性心
(心
)患者心室率的即时效应及安全性。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Atrial fibrillation and sinus tachycardiac may worsen hemodynamic change and heart function.
房颤和窦加重血流动力学改变和使心功能恶化。
Objective To evaluate the efficacy and safety of intravenous diltiazem and cediland (lanatoside C) for treatment of rapid ventricular rate in atrial fibrillation and flutter.
目的观察和比较静脉注射地尔硫、毛花甙C控制快心房颤动(房颤)和心房扑动(房扑)心室率的即时
效及安全性。
Objective To evaluate the efficacy and safety of intravenous fenopraine and lanatoside C for the treatment of rapid ventricular rate in patients with atrial fibrillation and congestive heart failure.
目的比较静脉应用普罗帕酮与毛花苷快
心房颤动(简称房颤)并发充血性心力衰竭(心衰)患者心室率的即时效应及安全性。
声明:以上、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Atrial fibrillation and sinus tachycardiac may worsen hemodynamic change and heart function.
颤和窦
加重血流动力学改变和使
功能恶化。
Objective To evaluate the efficacy and safety of intravenous diltiazem and cediland (lanatoside C) for treatment of rapid ventricular rate in atrial fibrillation and flutter.
目的观察和比较静脉注射地尔硫、毛花甙C控颤动(
颤)和
扑动(
扑)
室率的即时疗效及安全性。
Objective To evaluate the efficacy and safety of intravenous fenopraine and lanatoside C for the treatment of rapid ventricular rate in patients with atrial fibrillation and congestive heart failure.
目的比较静脉应用普罗帕酮与毛花苷丙治疗颤动(简称
颤)并发充血性
力衰竭(
衰)患者
室率的即时效应及安全性。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Atrial fibrillation and sinus tachycardiac may worsen hemodynamic change and heart function.
颤
窦
加重血流动力学改变
使
功能恶化。
Objective To evaluate the efficacy and safety of intravenous diltiazem and cediland (lanatoside C) for treatment of rapid ventricular rate in atrial fibrillation and flutter.
目的观察比较静脉注射
、毛花甙C控制快
颤动(
颤)
扑动(
扑)
室率的即时疗效及安全性。
Objective To evaluate the efficacy and safety of intravenous fenopraine and lanatoside C for the treatment of rapid ventricular rate in patients with atrial fibrillation and congestive heart failure.
目的比较静脉应用普罗帕酮与毛花苷丙治疗快颤动(简称
颤)并发充血性
力衰竭(
衰)患者
室率的即时效应及安全性。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Atrial fibrillation and sinus tachycardiac may worsen hemodynamic change and heart function.
房颤和窦加重血流动力学改变和使
功能恶化。
Objective To evaluate the efficacy and safety of intravenous diltiazem and cediland (lanatoside C) for treatment of rapid ventricular rate in atrial fibrillation and flutter.
目的观察和比较静脉注射地尔硫、毛花甙C控制快房颤动(房颤)和
房扑动(房扑)
室率的即时疗效及安全性。
Objective To evaluate the efficacy and safety of intravenous fenopraine and lanatoside C for the treatment of rapid ventricular rate in patients with atrial fibrillation and congestive heart failure.
目的比较静脉应用普罗帕酮与毛花苷丙治疗快房颤动(简称房颤)并发充血性
力
竭(
)
者
室率的即时效应及安全性。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。